Updated: August 2026
Please note that all expected publication dates are estimates and are subject to change based on a number of factors.
| Title | Stage of development | Expected publication date |
|---|---|---|
| (new) Care of Transgender and Gender Diverse Adults within Obstetrics and Gynaecology | Final draft stage (post-peer review) | To be confirmed |
| (no. 42) Shoulder Dystocia |
Final draft stage (post-peer review) |
August 2026 |
| (new) Non-Invasive Prenatal Testing |
Final draft stage (post-peer review) |
November 2026 |
| (27b) Vasa Praevia: Diagnosis and Management |
Final draft stage (post-peer review) |
March 2027 |
| (no. 36) The Prevention of Group B Streptococcal Disease in pregnancy, labour, neonatal and early infant life |
Final draft stage (post-peer review) |
May 2027 |
| (no. 41) Management of Chronic Pelvic Pain |
Final draft stage (post-peer review) |
May 2027 |
| (no. 37a) Reducing the risk of thrombosis and embolism during pregnancy and the puerperium |
Third Draft |
May 2027 |
| (no. 29) Management of Third and Fourth degree tears following vaginal birth |
Third Draft |
August 2027 |
| (no. 20) Epilepsy in Pregnancy |
Third Draft |
September 2027 |
| (new) Termination of Pregnancy for Fetal Anomaly |
Second Draft |
September 2027 |
| (no. 52a) Prevention of Postpartum Haemorrhage |
Second Draft |
November 2027 |
| (no. 52b) Management of Postpartum Haemorrhage |
Second Draft |
December 2027 |
| (no. 21) Diagnosis and Management of Ectopic Pregnancy |
Third Draft |
December 2027 |
| (no. 49) Laparoscopic entry and risk reduction techniques in gynaecological surgery |
Third Draft |
January 2028 |
| (no. 63) Antepartum Haemorrhage |
First Draft |
January 2028 |
| (no. 72) Care of women with obesity in pregnancy |
First Draft |
February 2028 |
| (no. 37b) Thrombosis and Embolism during Pregnancy and the Puerperium: Acute Management |
First Draft |
April 2028 |
| (new) Alternatives to HRT |
First Draft |
April 2028 |
| (new) Care and management of women with mid-trimester losses |
First Draft |
May 2028 |
More information
- For any queries regarding these guidelines, please email clinicaleffectiveness@rcog.org.uk.
- You can read our guidance document, Developing a Green-top Guideline: Guidance for developers, to learn about how Green-top Guidelines are developed.